What Is the Most Important Thing to Do to Defend Against DEA, OIG, FBI, and IRS Opioid Fraud Investigations?

Retain counsel before you respond to anyone. Before you produce a single document, before you return a telephone call from an agent whose name you wrote on a sticky note and placed beside your prescription pad, before you mention the inquiry to your office manager or your spouse, retain counsel. Everything that follows in this article is subordinate to that instruction.

The instinct of most physicians confronting federal scrutiny is to address the problem the way they address clinical problems: gather information, assess the situation, formulate a response. That instinct will produce the worst possible outcome. A multi-agency opioid investigation is not a diagnostic exercise. It is a coordinated institutional apparatus in which four or more federal agencies, each with distinct legal authorities and distinct evidentiary objectives, are constructing separate cases from the same set of facts about your practice, your prescribing, your finances, and whether the things you said to one agency can be repurposed by another.

Four agencies, one physician, no shared defense

The DEA investigates whether your prescribing occurred within the usual course of professional practice. The OIG investigates whether you submitted false claims to Medicare or Medicaid. The FBI investigates the criminal fraud theory, the conspiracy counts, the wire fraud allegations that attach to electronic billing. And the IRS Criminal Investigation division follows the money, comparing your reported income against deposits, tracing proceeds, constructing the tax evasion or money laundering charges that transform a healthcare case into a financial crime. In a Houston case concluded in 2024, a pharmacy owner received nineteen years of imprisonment for opioid distribution and tax fraud, the IRS having established that his reported income bore no rational relationship to the deposits flowing through his accounts.

These agencies share information. They share it freely, pursuant to formal coordination protocols, and they do so while presenting themselves to you as separate encounters with separate purposes.

The physician perceives four separate conversations. The government is conducting one investigation with four instruments.

Under Department of Justice Justice Manual Section 1-12.000, criminal and civil prosecutors are required to coordinate, to share discovery, to brief one another on their respective findings. The Yates Memorandum of 2015 formalized what had been occurring in practice for years: early and regular communication between civil attorneys and criminal prosecutors. A document you produce in response to a DEA administrative subpoena can be shared with the OIG. Information you disclose to a state licensing board can be provided to the FBI. What you report to your malpractice carrier can, through discovery in a civil proceeding, reach the desk of an AUSA assembling a criminal indictment.

The coordination is structural. Your response must be structural as well.

The single attorney is not sufficient

I want to correct something I was inclined to write, which is that retaining “an attorney” solves the problem. It does not. What is required is counsel experienced in parallel proceedings involving healthcare providers, someone who has sat across from DEA diversion investigators and AUSA healthcare fraud coordinators in the same quarter, someone who understands that the administrative hearing before an ALJ on your DEA registration and the grand jury proceeding examining your prescribing patterns are not separate legal events but interconnected mechanisms that share witnesses, share documents, and share the capacity to produce statements that migrate between forums.

A real estate attorney cannot perform this function. A general criminal defense practitioner, even a competent one, will not perceive the interaction between the DEA’s Order to Show Cause and the parallel criminal exposure until both have advanced past the point of strategic intervention. This is a practice area in which the temporal window for effective action is measured in weeks, not months, and it begins to close the moment you become aware of the investigation.

What early counsel controls that late counsel cannot

Before charges are filed, before the grand jury returns an indictment, before the DEA issues an Immediate Suspension Order, defense counsel possesses a set of instruments that vanish once the proceeding formalizes. Counsel can engage with the assigned AUSA and present the clinical context for prescribing decisions that, viewed through a spreadsheet of dosage quantities and patient overlap, appear criminal. Counsel can commission an independent audit (which the firm would retain a pharmacological expert to conduct, along with a billing compliance specialist and, where the IRS is involved, a forensic accountant whose findings remain protected under attorney-client privilege) that identifies and remediates compliance deficiencies before the government characterizes them as evidence of intent.

Counsel can negotiate the scope of document production. Counsel can ensure that responses to administrative subpoenas do not inadvertently waive privileges that protect against criminal exposure. Counsel can prevent you from submitting to a voluntary interview that produces a DEA-6 report containing your own words reframed as admissions.

But perhaps the most significant function of early counsel is the construction of a unified defense posture across all four agencies. Without coordination, a physician responds to each inquiry in isolation. The DEA receives one set of representations. The OIG receives another. The IRS receives financial disclosures that may be consistent with one theory but inconsistent with another. The contradictions between these separate responses become, in the government’s hands, evidence of consciousness of guilt.

The Fifth Amendment does not operate the way you assume

Most physicians believe they can simply decline to answer questions. They cannot, or rather, they can, but the legal consequences of how they decline vary across proceedings in ways that will surprise them.

In the criminal investigation, the Fifth Amendment privilege against self-incrimination is absolute. You cannot be compelled to testify before a grand jury without immunity, and your silence cannot be used against you at trial. But the administrative proceeding on your DEA registration operates under different rules. In a hearing before an administrative law judge, the DEA can draw adverse inferences from your refusal to testify. Your silence in the administrative forum, if not managed with precision, can result in the revocation of your registration while simultaneously being insulated from use in the criminal case by constitutional protections that apply only if properly invoked.

And the civil proceeding, the False Claims Act qui tam action or the OIG exclusion process, occupies a third constitutional space. The Fifth Amendment applies, but its invocation in a civil proceeding permits the factfinder to draw negative inferences, a consequence that does not attach in the criminal context.

Whether a physician can thread these three procedural needles without experienced counsel, maintaining silence where silence is protected, offering testimony where testimony is required, and preventing statements from one forum from contaminating another, is a question worth posing. No one in our experience has managed it alone.

The proffer trap

At some point in a multi-agency investigation, the government will offer what appears to be an opportunity. A proffer session. A “queen for a day” agreement. The premise is seductive: you tell the government what you know, and your statements cannot be used against you in court. The reality operates like a trapdoor installed in a floor that has already been measured for the fall.

The proffer agreement protects against direct use of your statements. It does not protect against derivative use. Every name you mention, every billing practice you describe, every clinical decision you explain becomes a lead the government can pursue independently. The agents in the room are trained to extract information you did not intend to provide. A physician who sits for a proffer session and mentions, in passing, that a colleague handled certain aspects of controlled substance documentation has just handed the government a cooperating witness it did not previously possess. The colleague, confronted with the physician’s statement, provides additional details. At trial, those details are admissible. The proffer agreement has functioned precisely as designed, which is to say, it has functioned for the government.

And there is a further danger that physicians underestimate. Minimization during a proffer constitutes confession. “I knew we were sometimes behind on documentation, but I believed the prescribing was appropriate” concedes the knowledge element the government must prove. You have not explained your innocence. You have supplied the mens rea.

The timeline you cannot perceive

DEA opioid investigations run twenty-four to thirty-two months from initial data gathering to indictment. The ARCOS database flags your prescribing volume. A PDMP review identifies patient overlap with other providers under scrutiny. Undercover operatives may enter your practice. Former patients are interviewed. Pharmacy records are subpoenaed. Staff members are approached. And during this entire period, you know nothing. You see patients. You renew registrations. You attend continuing education. The investigation proceeds on a parallel track that is invisible to you until the moment it becomes visible, at which point the government possesses two years of evidence and you possess whatever you can recall of decisions made under clinical conditions you can no longer reconstruct.

This is why the earliest possible retention of counsel matters. Not because counsel can prevent the investigation. The investigation may already be underway. Counsel matters because the physician who retains representation at the first sign of inquiry, a subpoena for records, a licensing board complaint, a patient’s unusual deposition notice, a colleague’s offhand mention that agents visited the pharmacy, gains access to the only interval in which the defense can shape the evidentiary record rather than merely respond to it.

The government spends two years constructing the case. The physician who waits until indictment has two years of catching up to do, beginning from a position in which every document has already been interpreted by the prosecution.

The registration is the livelihood

And here the administrative and criminal tracks converge in a way that most physicians fail to anticipate. The DEA can issue an Immediate Suspension Order when it determines that your continued registration poses an imminent danger to public health or safety. That order takes effect upon service. It does not require a hearing. It does not require a finding of guilt. It requires only a showing of substantial likelihood that your prescribing will cause harm in the absence of suspension.

Once the registration is suspended, you cannot prescribe controlled substances. For a pain management specialist, an anesthesiologist, a psychiatrist, this is functional termination. Your practice collapses. Your income ceases. Your malpractice carrier receives notice. Your hospital privileges enter review. The entire structure of your professional life disintegrates not upon conviction but upon an administrative determination made by the same agency investigating you.

Counsel who is engaged early can, in some circumstances, negotiate a voluntary restriction of prescribing authority that preserves the registration while addressing the government’s safety concerns. Counsel can prepare and submit a corrective action plan, which 21 C.F.R. provides for, demonstrating remediation of the practices that triggered the investigation. The DEA is not obligated to accept such a plan. But the submission of a credible corrective action plan, prepared by attorneys who understand what the DEA’s administrative law judges regard as sufficient, has in our experience altered the trajectory of proceedings that were otherwise directed toward suspension.

You sign the agreement and then you discover what the agreement permitted.

Ruan changed the burden, not the danger

The Supreme Court’s 2022 decision in Ruan v. United States required the government to prove that a physician prescribed controlled substances knowing or intending that the prescriptions fell outside the usual course of professional practice. This was a significant doctrinal shift. It was also, if we are being precise about outcomes rather than doctrine, insufficient to protect most physicians under investigation. The decision has been invoked in at least fifteen ongoing prosecutions across ten states. Some of those invocations have produced favorable results. Many have not. The government adapted its charging strategy. It now constructs cases around evidence of subjective awareness, which means the physician’s own statements, the physician’s own emails, the physician’s own documentation practices become the central evidence of the mental state Ruan requires the prosecution to establish.

DEFENSE TEAM SPOTLIGHT

Todd Spodek

Lead Attorney & Founder

Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.

NY Bar Admitted Multi-State Licensed Federal Courts

Meet the Full Team

The 2025 National Health Care Fraud Takedown charged 324 defendants, including 96 licensed medical professionals, in connection with over fourteen billion dollars in alleged fraud. Seventy-four individuals faced opioid-specific charges involving distribution of more than fifteen million pills. The government seized over 245 million dollars in assets. Ruan did not prevent these prosecutions. It changed the evidentiary path the government must walk. And that path now runs directly through your words.

The convergence you did not anticipate

There is a particular silence that descends when a physician learns that the IRS is involved. The DEA investigation was alarming. The OIG subpoena was disorienting. But the IRS letter produces a different quality of attention, because it signals that the government has moved beyond prescribing practices into financial analysis, and financial analysis produces a second, independent basis for criminal liability that has nothing to do with whether your prescribing was medically appropriate.

An Illinois physician was sentenced to thirty-four months of imprisonment for evading 1.6 million dollars in taxes and committing healthcare fraud. A physician in Boston, Harvard-educated, was convicted for healthcare fraud, money laundering, conspiracy to defraud the IRS, and tax evasion. In each case, the IRS Criminal Investigation division constructed a parallel prosecution that would have resulted in imprisonment even if the healthcare fraud charges had been dismissed. The financial case stands alone.

This is the dimension of multi-agency investigations that single-issue defense strategies cannot address. A physician who retains counsel for the DEA matter and ignores the tax implications has defended one flank while leaving the other exposed. A physician who retains separate counsel for each proceeding without a coordinating defense attorney has created four independent responses to what the government regards as a single pattern of conduct.

What the first telephone call accomplishes

The initial consultation with experienced defense counsel is not a commitment to representation. It is a diagnostic event. Counsel reviews the nature and source of the inquiry, the agencies involved, the stage of the investigation, the physician’s prescribing history, the financial exposure, and the status of any related administrative proceedings. From that assessment, counsel can determine whether the matter is likely to resolve at the administrative level, whether criminal exposure exists, whether the physician’s prescribing practices fall within defensible clinical parameters under the Ruan standard, and whether immediate protective measures are required to prevent the loss of the DEA registration.

That telephone call costs hours. Its absence costs careers.

If you are a physician, pharmacist, or healthcare provider who has received any form of federal inquiry, from any agency, at any stage, the consultation is where the defense begins.

The agencies will continue to coordinate. The question is whether your response will be coordinated as well. Beyond the specifics of any single investigation, there exists a broader truth about the relationship between the medical profession and the federal enforcement apparatus, one that has been recalibrated over the past decade in ways that most practicing physicians have not absorbed. The profession trains its members to document, to disclose, to cooperate. The enforcement system rewards those who do none of these things without counsel present. That misalignment is not an accident of policy. It is a structural condition, and it will persist long after any individual investigation concludes.